NCT06504472 - A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 7, 2024

Primary Completion Date

June 24, 2024

Study Completion Date

June 24, 2024

Conditions

Lower Urinary Tract SymptomsBenign Prostatic HyperplasiaErectile Dysfunction

Interventions

DIETARY_SUPPLEMENT

ProstaThrive™ Supplement

Participants in this arm will take three ProstaThrive™ capsules daily after the final meal of the day for 90 days.

DIETARY_SUPPLEMENT

Placebo

Participants in this arm will take three placebo capsules daily after the final meal of the day for 90 days. The placebo capsules will contain an inert substance that mimics the appearance of the ProstaThrive™ supplement.

Trial Locations (1)

90404

Citruslabs, Santa Monica